FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) 01069 | 說明 | 普通股 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | 每股發行/ ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本公告僅供參考，並不構成收購、購買或認購任何證券的邀請或要約。 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股份代號：1069） 完成根據一般授權配售新股份 配售代理 昌利證券有限公司 茲提述本公司日期為二零二五年七月二十二日內容有關根據一般授權配售新股份 之公告（「該公告」）。除另有界定者外，本公告所用詞彙與該公告所界定者具有相 同涵義。 完成根據一般授權配售新股份 董事會欣然宣佈，配售協議的所有條件已獲達成，而配售事項已於二零二五年八 月一日完成。合共17,000,000股配售股份已根據配售協議之條款及條件按配售價每 股配售股份0.28港元配發及發行予不少於六名承配人，相當於緊隨完成後經配發 及發行配售股份擴大之本公司已發行股本約16.52%。據董事經作出一切合理查詢 1 後所深知、盡悉及確信，(i) 各承配人為獨立第三方；及(ii) 概無承配人於緊隨配售 事項完成後成為主要股東（ ...

Group 1 - Nanshan Aluminum International (02610.HK) expects a mid-term net profit of approximately $225 million to $265 million for the six months ending June 30, 2025, compared to a net profit of about $159 million for the same period ending June 30, 2024 [1] - The increase in net profit is primarily attributed to an improvement in gross margin, driven by higher alumina prices and relatively stable unit production costs [1] - The average selling price of the company's products for the first half of 2025 is expected to be around $530 per ton, up from approximately $387 per ton in the first half of 2024, but lower than $561 per ton in the second half of 2024 [1] Group 2 - TCL Electronics (01070.HK) anticipates a year-on-year adjusted net profit growth of approximately 45% to 65% for the first half of 2025 [2] - Renrui Talent (06919.HK) expects a mid-term profit attributable to equity holders to increase by 66.7% to 94.1% [2] - China Rare Earth Holdings (03788.HK) reports an increase in total gold resources to 5.07 million ounces [2]

根据联交所获得的证据，王先生（该公司当时的借贷业务负责人）前后批准该公司授出及/或延长八笔 涉及本金金额合共1.383亿港元的贷款，事前却没有进行足够的尽职审查、风险分析及信贷评估，亦未 有妥善评估及监察相关抵押资产是否充足。部分贷款人为王先生家人，但无证据显示王先生有就此申 报。该公司2019年全年业绩中就应收贷款作出了约86%的减值。 王先生及田女士亦被发现曾于2018年该公司出售若干附属公司时，促使该公司在无担保及免息的基础上 允许将买方支付代价9300万元人民币的限期押后到出售事项完成后数月。买方最后并未支付任何代价， 导致该公司2019年全年业绩录得9300万元人民币的全额减值。概无证据显示王先生或田女士于出售事项 前有对买方进行任何尽职审查或信贷评估。 智通财经APP获悉，5月28日，香港联合交易所有限公司宣布对中国健康科技集团控股有限公司(01069) （前称中国宝沙发展控股有限公司）两名前董事王岳和田光梅作出纪律处分。联交所认为二人不适合担 任公司或其附属公司的董事或高级管理职务，原因是他们在2015年至2019年从事公司借贷业务及2018年 促使公司出售附属公司时，未履行董事职责，且未配合联 ...

Revenue and Profitability - For the six months ended December 31, 2024, the company recorded revenue of approximately RMB 31,100,000, an increase from RMB 19,000,000 in the previous period, representing a growth of 63.16%[15] - The company generated timber sales revenue of approximately RMB 11,560,000 from the sale of 8,547 cubic meters of timber during the reporting period[9] - Ginseng business revenue amounted to approximately RMB 16,150,000, which includes RMB 10,770,000 from purchased ginseng and RMB 5,380,000 from self-cultivated ginseng[11] - The health products segment recorded revenue of approximately RMB 3,400,000 during the reporting period[12] - The gross profit for the reporting period was approximately RMB 2,800,000, down from RMB 3,800,000 in the previous period, indicating a decline of 26.32%[16] - The company recorded a profit of approximately RMB 5,000,000 during the reporting period, a significant decline from approximately RMB 201,400,000 in the previous period[21] - Revenue for the six months ended December 31, 2024, was RMB 31,112,000, an increase of 63.5% compared to RMB 19,020,000 for the same period in 2023[51] - Gross profit for the same period was RMB 2,777,000, down 26.2% from RMB 3,758,000 in 2023[51] - The company reported a profit before tax of RMB 5,042,000, significantly lower than RMB 201,423,000 in the previous year, primarily due to a one-time debt restructuring gain in 2023[51] - Net profit for the period was RMB 4,978,000, compared to RMB 201,421,000 in the prior year[51] - Total comprehensive income for the period was RMB 6,353,000, down from RMB 207,869,000 in 2023[51] Assets and Liabilities - As of December 31, 2024, the total assets of the group were approximately RMB 191,100,000, with net assets of approximately RMB 24,900,000 and cash and bank balances of approximately RMB 2,700,000[22] - The capital debt ratio as of December 31, 2024, was approximately 87.0%, down from 92.7% on June 30, 2024[26] - The total number of issued ordinary shares as of December 31, 2024, was 859,242,204 shares, an increase from 716,242,204 shares on June 30, 2024[27] - Non-current assets as of December 31, 2024, totaled RMB 137,728,000, an increase from RMB 130,844,000 as of June 30, 2024[52] - Current assets increased to RMB 53,357,000 from RMB 47,322,000 as of June 30, 2024[52] - Current liabilities rose to RMB 53,356,000 from RMB 49,315,000 as of June 30, 2024[52] - The company's net asset value increased to RMB 24,869,000 from RMB 12,963,000 as of June 30, 2024[53] - Total assets increased to RMB 191,085,000 as of December 31, 2024, up from RMB 178,166,000 as of June 30, 2024[69] - Total liabilities rose to RMB 166,216,000, compared to RMB 165,203,000 in the previous period[71] Expenses and Costs - Sales and distribution expenses during the reporting period were RMB 148,000, a significant decrease from RMB 623,000 in the previous period, primarily due to advertising expenses[17] - Administrative expenses increased by 11.9% from approximately RMB 8,400,000 in the previous period to approximately RMB 9,400,000, mainly due to legal and professional fees as well as depreciation expenses[18] - Financing costs rose to RMB 1,300,000 during the reporting period, up from approximately RMB 100,000 in the previous period, due to interest on promissory notes[20] - Employee costs totaled RMB 1,528,000, a decrease from RMB 1,884,000 in the previous year[77] - The cost of harvested timber was RMB 11,564,000, down from RMB 15,262,000 in the previous year[77] Cash Flow and Financing - Operating cash flow for the six months ended December 31, 2024, was RMB 1,769,000, down from RMB 3,293,000 in the same period of 2023[55] - The total cash and cash equivalents at the end of the period were RMB 2,676,000, a decrease from RMB 3,230,000 at the beginning of the period[55] - The company’s financing activities generated a net cash inflow of RMB 3,831,000 during the period[55] - The company issued a total of RMB 120,000,000 in notes secured by land, with varying interest rates from 0% to 6% over five years[101] Shareholder Information - The company maintained a public float of no less than 25% of its issued shares as required by listing rules[48] - The total issued and paid-up ordinary shares increased to 859,242,000 shares, up from 716,242,000 shares, an increase of 19.9%[102] - No dividends were declared or proposed for the six months ended December 31, 2024, consistent with the previous period[80] Ginseng and Timber Operations - The company has obtained a logging permit for 2024, allowing for a total logging volume of 8,547 cubic meters, which is higher than the previous year's logging volume[13] - The company plans to reduce reliance on suppliers by cultivating its own aged ginseng stock, aiming for self-sufficiency in ginseng production[13] - The company has initiated the manufacturing and trading of health products since November 2024, with plans to expand its market presence in China[13] - The company successfully planted its first batch of Epimedium on its owned forest land in June 2024, which is expected to generate future revenue[14] - The company has signed a legally binding framework agreement with independent suppliers for ginseng cultivation, ensuring a stable supply of ginseng seeds and technical support for a period of 10 years[10] - The forestry business generated revenue of RMB 11,564,000, while the ginseng business contributed RMB 16,152,000, and health products generated RMB 3,396,000[68] Risk Management - The company has implemented extensive measures to monitor and mitigate risks related to climate change, pests, and natural disasters affecting timber growth[94] - The company faces risks related to fluctuations in timber prices and sales volumes, and management conducts regular industry trend analyses to align pricing structures with market conditions[95] Taxation - The company reported a tax expense of RMB 64,000 for the six months ended December 31, 2024, compared to RMB 2,000 for the same period in 2023, indicating a significant increase[78] - The effective tax rate for qualifying group entities in Hong Kong is 8.25% on the first HKD 2 million of taxable profits and 16.5% on profits above that threshold[79] - The company has not reported any taxable profits for the current and previous periods, resulting in no tax provisions in the consolidated financial statements[79] Other Financial Information - Other income for the reporting period was approximately RMB 13,100,000, compared to approximately RMB 4,700,000 in the previous period, with the increase mainly attributed to the net gain from the fair value change of artificial forest assets[19] - Other total income net amount was RMB 13,140,000, significantly up from RMB 4,726,000 in the previous year[72] - The company has not issued any diluted earnings per share due to the absence of potential dilutive ordinary shares during the reporting periods[83]

Financial Performance - The company's revenue for the six months ended December 31, 2024, was RMB 31,112,000, representing a 63.5% increase compared to RMB 19,020,000 for the same period in 2023[4] - Gross profit for the same period was RMB 2,777,000, down 26.2% from RMB 3,758,000 in the previous year[4] - The company reported a pre-tax profit of RMB 5,042,000, a significant decrease from RMB 201,423,000 in the prior period, largely due to a one-time debt restructuring gain in the previous year[4] - The net profit for the six months was RMB 4,978,000, compared to RMB 201,421,000 in the previous year[4] - Total comprehensive income for the period was RMB 6,353,000, down from RMB 207,869,000 in the same period last year[4] - The net profit for the six months ended December 31, 2024, was RMB 4,978,000, compared to RMB 201,421,000 for the same period in 2023, showing a significant decrease due to restructuring costs[19][24] - The company recorded a debt restructuring gain of approximately RMB 202,024,000 during the review period, significantly impacting the financial results[24] - The financing costs for the six months ended December 31, 2024, were RMB 1,337,000, a notable increase from RMB 51,000 in the previous period[22] - The company reported a profit of approximately RMB 5,000,000, a significant decrease from RMB 201,400,000 in the previous period[49] Assets and Liabilities - The company's non-current assets totaled RMB 137,728,000 as of December 31, 2024, an increase from RMB 130,844,000 as of June 30, 2024[5] - Current assets increased to RMB 53,357,000 from RMB 47,322,000 in the previous period[5] - The company's total liabilities were RMB 53,356,000, compared to RMB 49,315,000 in the previous period, indicating a rise in financial obligations[6] - The total assets as of December 31, 2024, amounted to RMB 191,085,000, up from RMB 178,166,000 as of June 30, 2024, reflecting a growth of 7.1%[20] - The total liabilities increased to RMB 171,826,000 from RMB 165,203,000, indicating a rise of 4.0%[20] - As of December 31, 2024, the company had total assets of approximately RMB 191,100,000 and net assets of approximately RMB 24,900,000[50] - The capital debt ratio was approximately 87.0%, improved from 92.7% as of June 30, 2024[54] Business Segments - The company is engaged in forestry management, ginseng cultivation and trade, and health product manufacturing, indicating a diversified business model[8] - The forestry business generated revenue of RMB 11,564,000, while the ginseng business contributed RMB 16,152,000, indicating strong performance in these segments[19] - The health products segment generated revenue of RMB 3,396,000, contributing positively to the overall performance[19] - The company achieved a total revenue of approximately RMB 11,560,000 from timber sales during the reporting period, with a total harvesting volume of 8,547 cubic meters[36] - Ginseng business revenue reached approximately RMB 16,150,000, which includes RMB 10,770,000 from purchased ginseng and RMB 5,380,000 from self-cultivated ginseng[39] - The health products segment generated revenue of approximately RMB 3,400,000 since its launch in November 2024[40] - The company has initiated a health product manufacturing and trading business, with plans to produce ginseng gift boxes using self-cultivated ginseng by the first half of 2025[40] - The company has secured a harvesting permit for 2024, allowing for the planned timber sales to continue[36] - The company has established a long-term supply framework agreement with suppliers to ensure a stable supply of ginseng for its trading business[39] Governance and Compliance - The company has adopted all provisions of the corporate governance code as per the listing rules, ensuring compliance throughout the reporting period[68] - The board confirmed that all directors adhered to the code of conduct for securities trading during the reporting period[69] - The company has not purchased any liability insurance for directors and executives against legal claims as of December 31, 2024[70] - The audit committee, consisting of three independent non-executive directors, focuses on compliance with accounting standards and legal regulations[71] - The unaudited interim financial statements have been reviewed by the audit committee during the reporting period[72] - The interim results announcement will be published on the Hong Kong Stock Exchange and the company's website, containing all required information[73] - The board includes both executive and independent non-executive directors, ensuring a diverse governance structure[75] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to drive future growth[19] - The company successfully planted its first batch of Epimedium on its owned forest land in June 2024, which is expected to generate revenue in the future[42]

Financial Performance - For the fiscal year ending June 30, 2024, the company's revenue was approximately RMB 47,600,000, compared to RMB 58,717,000 for the fiscal year ending June 30, 2023, representing a decrease of about 19%[1] - The profit attributable to the owners of the company for the fiscal year 2024 was approximately RMB 200,000,000, a significant recovery from a loss of RMB 10,800,000 in the fiscal year 2023[1] - The total comprehensive income attributable to the owners for the fiscal year 2024 was approximately RMB 204,000,000, compared to a total comprehensive loss of RMB 10,100,000 in the fiscal year 2023[1] - Basic earnings per share for fiscal year 2024 were RMB 29.79, a recovery from a loss of RMB 9.80 per share in fiscal year 2023[1] - The company reported a net profit of RMB 200,013 thousand for the year ended June 30, 2024, compared to a net loss of RMB 10,800 thousand for the year ended June 30, 2023[15] - In fiscal year 2024, the company recorded a profit of approximately RMB 200,000,000, compared to a loss of approximately RMB 10,800,000 in fiscal year 2023[53] - The total comprehensive income attributable to the owners of the company for fiscal year 2024 was approximately RMB 204,000,000, while the total comprehensive expense for fiscal year 2023 was approximately RMB 10,100,000[53] Revenue Breakdown - Total revenue for the group decreased to RMB 47,606 thousand in 2024 from RMB 58,717 thousand in 2023, representing a decline of approximately 19%[13] - Forestry business revenue increased to RMB 32,521 thousand in 2024 from RMB 25,603 thousand in 2023, a growth of about 27%[15] - The ginseng business generated total revenue of approximately RMB 15,100,000 in fiscal year 2024, including RMB 12,540,000 from purchased ginseng and RMB 2,560,000 from self-cultivated ginseng[43] - The forestry management business generated revenue of approximately RMB 32,500,000 from the sale of 16,260 cubic meters of timber in fiscal year 2024[41] Expenses and Costs - The gross profit for fiscal year 2024 was RMB 1,897,000, down from RMB 11,510,000 in fiscal year 2023, indicating a decline in profitability[3] - Administrative expenses increased by 11.8% to approximately RMB 21,500,000 in fiscal year 2024, up from RMB 19,200,000 in fiscal year 2023[48] - The total employee costs for the year were RMB 3,308,000, down from RMB 5,326,000 in the previous year, reflecting a reduction of 37.9%[27] - The company incurred costs of RMB 32,522,000 for harvested timber, an increase from RMB 25,603,000 in the previous year[27] - The depreciation expense for right-of-use assets was RMB 4,880,000, compared to RMB 2,509,000 in the previous year, indicating a significant increase[27] Assets and Liabilities - The company's capital-to-debt ratio improved to approximately 92.7% in fiscal year 2024, down from 325.2% in fiscal year 2023, a decrease of 232.5 percentage points[1] - Total assets increased to RMB 178,166 thousand in 2024 from RMB 140,643 thousand in 2023, reflecting a growth of approximately 27%[17] - Total liabilities decreased significantly to RMB 165,203 thousand in 2024 from RMB 457,351 thousand in 2023, a reduction of about 64%[17] - The total assets less current liabilities amounted to RMB 12,963,000 in fiscal year 2024, a significant improvement from a negative net asset position of RMB (316,708,000) in fiscal year 2023[7] - As of June 30, 2024, the company had total assets of approximately RMB 178,200,000 and net assets of approximately RMB 13,000,000[54] Debt and Financing - The company reported a debt restructuring gain of RMB 202,024,000 in fiscal year 2024, which contributed significantly to the overall profit[3] - Financing costs from continuing operations for fiscal year 2024 were approximately RMB 3,200,000, a decrease of about 72.4% from RMB 11,700,000 in fiscal year 2023[52] - The company issued 140,000,000 shares at an issue price of HKD 0.55, raising approximately HKD 77,000,000 (approximately RMB 70,610,000) as part of the creditor plan[51] - As of June 30, 2024, there were no outstanding unsecured corporate bonds, compared to approximately HKD 279,769,000 as of June 30, 2023[58] - The company has not experienced significant foreign exchange or interest rate volatility risks during the fiscal year 2024, and currently has no foreign exchange hedging policies in place[62] Dividends - The company did not recommend any dividend distribution for fiscal year 2024, consistent with fiscal year 2023[1] - The company did not declare or propose any dividends for the year ended June 30, 2024, consistent with the previous year[28] - The company has not proposed any dividends for the fiscal year 2024, consistent with the previous fiscal year[69] Auditor and Governance - The independent auditor's report expressed a qualified opinion regarding the fair value measurement of certain assets, specifically artificial forest assets valued at RMB 48,420,000 and ginseng assets at RMB 22,000,000 as of June 30, 2023[35] - The board and audit committee acknowledged the auditor's qualified opinion and confirmed their agreement with the auditor's findings[37] - The audit committee was established in September 2009, consisting of three independent non-executive directors[76] - The audit committee reviews the company's financial reporting processes and internal control systems before submitting interim and annual reports to the board[76] - The company has adopted all the corporate governance code provisions as per the listing rules and believes it has complied with them during the fiscal year 2024[73] Employee Information - The company has a total of 33 employees and management personnel as of June 30, 2024, an increase from 18 employees in the previous year[65] - The total employee cost for the reporting period is approximately RMB 3,300,000, compared to RMB 5,300,000 in the previous fiscal year[65]

Revenue Generation - The group generated revenue of approximately RMB 5,400,000 from timber sales during the reporting period, with a total harvesting volume of 12,044.0 cubic meters approved for the year 2023[11]. - The ginseng business reported revenue of approximately RMB 13,600,000, sourced from purchasing ginseng from suppliers[13]. - The group’s revenue for the six months ended December 31, 2023, was RMB 19,020,000, a decrease of 17.3% compared to RMB 23,021,000 for the same period in 2022[77]. - Forestry business revenue was RMB 5,440,000, while ginseng business revenue was RMB 13,580,000, contributing to the total revenue[99]. - Total revenue for the six months ended December 31, 2023, was RMB 19,020,000, a decrease of 17.3% from RMB 23,021,000 for the same period in 2022[96]. Ginseng Business Development - The group has initiated a ginseng planting program on 59 acres of land, with an expected phased sale of approximately 6 million ginseng plants over five years[13]. - The group aims to reduce reliance on suppliers by cultivating its own aged ginseng stock, ensuring quality through self-seeding methods[16]. - The group has established long-term supply agreements with suppliers to ensure a stable supply of aged ginseng[13]. - The group is actively working on increasing its inventory of aged ginseng to capture market share in the Chinese ginseng industry[16]. - The group has successfully completed the first phase of its ginseng planting plan, which began in December 2022[13]. Financial Performance - The company recorded revenue of approximately RMB 19,000,000 during the reporting period, a decrease of 17.4% compared to RMB 23,000,000 in the previous period[30]. - Gross profit for the reporting period was approximately RMB 3,800,000, down from RMB 5,100,000 in the previous period[31]. - The company recorded a profit of approximately RMB 201,400,000 during the reporting period, compared to a loss of approximately RMB 1,200,000 in the previous period[39]. - The total comprehensive income attributable to the company during the reporting period was approximately RMB 207,900,000, while the previous period recorded a total comprehensive expense of approximately RMB 14,600,000[39]. - The group reported a total profit of RMB 201,421,000 for the six months ended December 31, 2023, compared to a loss of RMB 1,244,000 for the same period in 2022[99][101]. Debt Restructuring and Capital Management - The company recorded a debt restructuring gain of approximately RMB 202,020,000 during the reporting period[35]. - The company completed a capital restructuring on July 14, 2023, with the trading unit changing from 40,000 shares to 16,000 new shares[23]. - The company issued 140,000,000 new shares at an issue price of HKD 0.55 per share as part of the creditor plan[25]. - The total amount raised from the subscription was HKD 466,000,000, with HKD 30,000,000 allocated to the plan company for distribution to creditors[24]. - The creditor plan was approved by the necessary statutory majority of creditors on May 18, 2023, and was sanctioned by the Hong Kong court on June 9, 2023[21]. Shareholder and Corporate Governance - Major shareholders include Zhonggang International Holdings Group Limited with 24.40% and China Bozza Scheme Limited with 19.55% of the issued share capital[58]. - The company has adopted all provisions of the Corporate Governance Code as per the listing rules[68]. - The board believes the company has complied with the Corporate Governance Code during the reporting period[68]. - No significant contracts were entered into by the company or its subsidiaries that involve directors' interests during the reporting period[63]. - The company has not purchased any directors' and officers' liability insurance as of December 31, 2023[68]. Asset and Liability Management - As of December 31, 2023, the company had total assets valued at approximately RMB 141,400,000 and net assets of approximately RMB 16,800,000[40]. - The company's total liabilities decreased significantly to RMB 110,034,000 from RMB 442,894,000, indicating improved financial stability[79]. - Total liabilities decreased from RMB 457,351,000 as of June 30, 2023, to RMB 124,616,000 as of December 31, 2023, representing a reduction of approximately 72.7%[102]. - The company’s capital debt ratio as of December 31, 2023, was approximately 88.1%, a significant improvement from 325.2% on June 30, 2023[45]. - The company recorded a fair value change of RMB 38,113,000 in artificial forest assets during the reporting period[120]. Operational Highlights - The company logged approximately 5,620 cubic meters of timber from the Kunlin forest, with a fair value of RMB 5,027,000 during the reporting period[123]. - The company has not logged any timber from the Hengchang forest during the review period, maintaining a total area of approximately 1,389 hectares[122]. - The total leased land for Ruixiang Forest is approximately 30,653 acres (about 2,044 hectares) as of December 31, 2023[126]. - No timber was harvested from Ruixiang Forest during the review period, with a total of 2,167 cubic meters reported for the six months ending December 31, 2022, and a fair value of zero for the harvested timber[126]. - The total leased land for Wantai Forest is approximately 42,814 acres (about 2,854 hectares) as of December 31, 2023[128]. Employee and Administrative Costs - The total employee cost during the reporting period was approximately RMB 1,900,000, compared to RMB 2,200,000 in the previous period[55]. - Administrative expenses increased by 55.6% to approximately RMB 8,400,000, up from approximately RMB 5,400,000 in the previous period, primarily due to legal and professional fees as well as depreciation[33]. - The company’s employee costs decreased from RMB 2,168,000 in the first half of 2022 to RMB 1,884,000 in the first half of 2023, a reduction of approximately 13.1%[110]. Changes in Management - Changes in the board include the appointment of Mr. Chen Weilong as CEO effective November 21, 2023[69]. - The management does not provide monthly updates to the board but ensures that necessary information is shared for performance assessment[70].

Financial Performance - For the six months ended December 31, 2023, the company's revenue was RMB 19,020,000, a decrease of 17.3% compared to RMB 23,021,000 for the same period in 2022[4] - Gross profit for the same period was RMB 3,758,000, down 26.0% from RMB 5,069,000 in the previous year[4] - The company reported a significant debt restructuring gain of RMB 202,024,000, leading to a pre-tax profit of RMB 201,423,000 compared to a loss of RMB 1,244,000 in the prior period[4] - The net profit for the period was RMB 201,421,000, a substantial recovery from a loss of RMB 1,244,000 in the previous year[4] - The total comprehensive income for the period was RMB 207,869,000, compared to a loss of RMB 14,634,000 in the same period last year[4] - The total profit for the six months ended December 31, 2023, was RMB 5,233,000, compared to RMB 10,833,000 for the same period in 2022, reflecting a decline of 51.7%[21] - The company recorded a pre-tax profit of RMB 201,423,000 for the six months ended December 31, 2023, compared to a pre-tax loss of RMB 1,244,000 for the same period in 2022[21] - The company achieved a profit of approximately RMB 201,400,000 during the reporting period, a significant turnaround from a loss of approximately RMB 1,200,000 in the previous period[51] Assets and Liabilities - The company's current assets decreased to RMB 19,160,000 from RMB 22,621,000 as of June 30, 2023[5] - Current liabilities significantly decreased to RMB 14,582,000 from RMB 442,894,000, indicating improved liquidity[5] - The company's total assets less current liabilities stood at RMB 126,856,000, a recovery from a negative position of RMB 302,251,000[5] - Total assets as of December 31, 2023, amounted to RMB 141,438,000, an increase from RMB 140,643,000 as of June 30, 2023[22] - Total liabilities decreased to RMB 124,616,000 as of December 31, 2023, from RMB 457,351,000 as of June 30, 2023, indicating a significant reduction in debt[22] - As of December 31, 2023, the company had total assets valued at approximately RMB 141,400,000 and net assets of approximately RMB 16,800,000[52] - The capital debt ratio as of December 31, 2023, was approximately 88.1%, a significant improvement from 325.2% on June 30, 2023[56] Business Operations - Forestry business revenue was RMB 5,440,000, down 36.5% from RMB 8,580,000 in the same period last year, while ginseng business revenue was RMB 13,580,000, a decrease of 6.0% from RMB 14,441,000[21] - The company successfully obtained a logging permit for 12,044.0 cubic meters in December 2023, with sales of approximately 5,620 cubic meters generating revenue of about RMB 5,400,000 during the reporting period[39] - The ginseng business generated revenue of approximately RMB 13,600,000 during the reporting period, sourced from the purchase of ginseng from suppliers[40] - The company has initiated ginseng cultivation in its existing forests, with a first phase planting of approximately 6 million ginseng seeds on 59 acres[40] - The company owns a total of 117,424 acres (approximately 7,829 hectares) of forest land in Sichuan Province, China, primarily consisting of cypress trees[38] - The company has established a long-term supply framework agreement with suppliers to ensure a stable supply of ginseng[40] Employee and Governance - As of December 31, 2023, the group had 27 employees, an increase from 16 employees as of December 31, 2022[65] - Total employee costs during the reporting period amounted to approximately RMB 1,900,000, down from RMB 2,200,000 in the previous period[65] - The board did not recommend the payment of an interim dividend for the reporting period, consistent with the previous period[66] - The company has adopted all code provisions of the Corporate Governance Code and has been compliant, with some exceptions noted[70] - The Audit Committee, consisting of three independent non-executive directors, reviewed the company's interim and annual reports[72] - The company's interim financial statements for the reporting period were reviewed by the Audit Committee[73] - The board of directors includes both executive and independent non-executive members, ensuring a diverse governance structure[76] Corporate Changes - The company has undergone a restructuring process, with shares resuming trading on July 28, 2023, after fulfilling the listing rules[8] - The company completed a capital and debt restructuring on July 28, 2023, and its shares resumed trading on the same day[34][35] - The company changed its name from "China Bozza Development Holdings Limited" to "China Health Technology Group Holding Company Limited" effective November 27, 2023[64] - There were no significant events after the reporting period that could materially impact the company's operations and financial performance[63] - The company agreed to acquire a 52% stake in a target company for RMB 7,128,670, which will become a non-wholly owned subsidiary[59] Financial Management - The company incurred financing costs of RMB 51,000 for the six months ended December 31, 2023, down from RMB 8,967,000 in the previous year[23] - The company’s bank interest income was RMB 2,000 for the six months ended December 31, 2023, compared to RMB 3,000 for the same period in 2022[22] - Administrative expenses increased by 55.6% to approximately RMB 8,400,000 from about RMB 5,400,000 in the previous period, primarily due to legal and professional fees as well as depreciation[46] - The company recorded a debt restructuring gain of approximately RMB 202,020,000, resulting from the difference between the settled debt's book value of approximately RMB 410,170,000 and the amounts issued to creditors[48] - The company reported a net loss attributable to shareholders of RMB 201,421 thousand for the six months ended December 31, 2023, compared to a loss of RMB 1,244 thousand for the same period in 2022[31] - Trade receivables decreased from RMB 6,933 thousand as of June 30, 2023, to RMB 4,212 thousand as of December 31, 2023[14] - Trade payables decreased from RMB 99,008 thousand as of June 30, 2023, to RMB 10,840 thousand as of December 31, 2023[15] - The company recorded revenue of approximately RMB 19,000,000 during the reporting period, a decrease of 17.4% compared to RMB 23,000,000 in the previous period[43] - Gross profit for the reporting period was approximately RMB 3,800,000, down from RMB 5,100,000 in the previous period, reflecting a decline of 25.5%[44]

Financial Performance - For the fiscal year ending June 30, 2023, the revenue from continuing operations was approximately RMB 58.7 million[7]. - The loss attributable to owners for the fiscal year was approximately RMB 10.8 million, a decrease from a loss of RMB 18.9 million in the previous fiscal year[7]. - The total comprehensive expenses for the fiscal year were approximately RMB 10.1 million, down from RMB 29.3 million in the previous fiscal year[7]. - For the fiscal year 2023, the company recorded revenue from continuing operations of approximately RMB 58,700,000, a significant increase from RMB 6,800,000 in the fiscal year 2022[29]. - The gross profit for fiscal year 2023 was approximately RMB 11,500,000, with a gross profit margin of 19.6%, attributed to satisfactory revenue from ginseng business[30]. - The company incurred a loss of approximately RMB 10,800,000 in fiscal year 2023, compared to a loss of RMB 18,900,000 in fiscal year 2022[36]. - The company reported a pre-tax loss of RMB 9,374,000 for the fiscal year ending June 30, 2023, an improvement from a loss of RMB 20,383,000 in the previous fiscal year[63]. - The total comprehensive loss for the year was RMB 10,073 thousand, down from RMB 29,316 thousand in the previous year, showing a decrease of approximately 66%[200]. Assets and Liabilities - As of June 30, 2023, the company's total assets were approximately RMB 140,600,000 and net liabilities were approximately RMB 316,700,000[37]. - As of June 30, 2023, the group's net current liabilities and net liabilities were approximately RMB 420,273,000 and RMB 316,708,000, respectively[21]. - Current liabilities exceeded current assets by approximately RMB 420,273,000 on June 30, 2023[164]. - The group reported a net debt of approximately RMB 316,708,000 as of June 30, 2023[164]. - As of June 30, 2023, the company's trade and other receivables amounted to RMB 10,399,000[188]. Capital Structure and Financing - As of June 30, 2023, the capital debt ratio was approximately 325.2%, a reduction of 24.0% from 427.9% in the previous year[7]. - The company completed a restructuring agreement on July 28, 2023, issuing 466,000,000 shares at HKD 0.1288 per share, raising approximately HKD 60,000,000[28]. - The company issued 140,000,000 shares at HKD 0.55 per share to creditors, raising approximately HKD 77,000,000 as part of the creditor scheme[28]. - The company issued HKD 120,000,000 in promissory notes to creditors with varying interest rates from 0% to 6% over five years[164]. - The company reported a financing cost of approximately RMB 11,700,000 for fiscal year 2023, a decrease of about 44.9% from RMB 21,200,000 in fiscal year 2022[34]. Ginseng and Forestry Business - The company completed the approved logging volume of approximately 26,953 cubic meters, generating logging revenue of approximately RMB 25.6 million during the fiscal year[12]. - The group's ginseng business generated revenue of approximately RMB 33,100,000 in the fiscal year 2023[15]. - The company has initiated ginseng cultivation in its existing forests, completing the first phase of planting approximately 6 million ginseng plants on 59 acres[14]. - In the fiscal year 2023, the group generated revenue of approximately RMB 25.6 million from forestry management and RMB 33.1 million from ginseng business[83]. Governance and Management - The company has over 18 years of experience in banking, insurance, fund management, and securities management[69]. - The executive team includes individuals with extensive backgrounds in business planning, financial management, and auditing, with over 42 years of experience in accounting and auditing collectively[73][74]. - The company is committed to maintaining high standards of compliance and governance, as evidenced by the qualifications of its board members and executives[74]. - The board consists of ten directors, including two female directors, achieving gender diversity with a target to maintain at least one female director[135]. - The board has adopted a diversity policy, considering various factors such as gender, age, cultural background, and professional experience for board member appointments[134]. Audit and Compliance - The independent auditor's report highlighted significant uncertainty regarding the group's ability to continue as a going concern[21]. - The audit committee acknowledged the independent auditor's report and the potential impact of adjustments on the financial statements[24]. - The Audit Committee, consisting of four independent non-executive directors, oversees the financial reporting process and internal control systems as of June 30, 2023[151]. - The internal control system has been reviewed and deemed effective for the fiscal year 2023, ensuring reasonable assurance against significant misstatements and fraud[160]. Shareholder Communication - The company has implemented measures to ensure effective communication with shareholders and investors[167]. - The company has reviewed its shareholder communication policy and found it to be effective[172]. - The board believes that the group will have sufficient cash resources to meet its operational funding and financial obligations for the next twelve months[165].